Substituted fused heterocyclic Cglycosides

Details for Australian Patent Application No. 2004261660 (hide)

International Classifications

Event Publications

5 October 2006 Section 223 Application Received

JANSSEN PHARMACEUTICA NV; TANABE SEIYAKU CO., LTD An application to extend the time from 01 Mar 2006 to 01 Aug 2006 in which to enter the National Phase has been filed . Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000

7 December 2006 Section 223 Application Allowed

Janssen Pharmaceutica NV; Tanabe Seiyaku Co., Ltd The time in which to enter the National Phase has been extended to 01 Aug 2006. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000

4 January 2007 PCT application entered the National Phase

PCT publication WO2005/012318 Priority application(s): WO2005/012318

11 January 2007 Change of Name(s) of Applicant(s), Section 104

Janssen Pharmaceutica NV; Tanabe Seiyaku Co., Ltd The name of the applicant has been changed to Janssen Pharmaceutica N.V.; Tanabe Seiyaku Co., Ltd

24 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.